Experimental gene therapy targets rare nerve disease

This study tested a gene transfer treatment for giant axonal neuropathy (GAN), a rare genetic disease that damages nerves and affects movement, breathing, and other functions. Fourteen people aged 3 and older received a single injection of the treatment into the fluid around the spinal cord. The main goal was to check safety, and researchers also looked for signs of improvement in nerve function.